NCT00320580View on ClinicalTrials.gov

An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen

PHASE2CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 2003

Conditions
Metrorrhagia
Interventions
DRUG

norelgestromin/ethinyl estradiol

All Listed Sponsors
lead

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

NCT00320580 - An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen | Biotech Hunter | Biotech Hunter